136 related articles for article (PubMed ID: 20176597)
1. Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease.
Godau J; Herfurth M; Kattner B; Gasser T; Berg D
J Neurol Neurosurg Psychiatry; 2010 May; 81(5):536-8. PubMed ID: 20176597
[TBL] [Abstract][Full Text] [Related]
2. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease.
Picillo M; Erro R; Santangelo G; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; Moccia M; Colao A; Barone P; Pellecchia MT
J Neurol; 2013 Jul; 260(7):1724-30. PubMed ID: 23400497
[TBL] [Abstract][Full Text] [Related]
4. Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.
Bernhard FP; Heinzel S; Binder G; Weber K; Apel A; Roeben B; Deuschle C; Maechtel M; Heger T; Nussbaum S; Gasser T; Maetzler W; Berg D
PLoS One; 2016; 11(3):e0150552. PubMed ID: 26967642
[TBL] [Abstract][Full Text] [Related]
5. Plasma insulin-like growth factor 1 is associated with cognitive impairment in Parkinson's disease.
Ma J; Jiang Q; Xu J; Sun Q; Qiao Y; Chen W; Wu Y; Wang Y; Xiao Q; Liu J; Tang H; Chen S
Dement Geriatr Cogn Disord; 2015; 39(5-6):251-6. PubMed ID: 25661865
[TBL] [Abstract][Full Text] [Related]
6. Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease.
Mashayekhi F; Mirzajani E; Naji M; Azari M
J Clin Neurosci; 2010 May; 17(5):623-7. PubMed ID: 20189394
[TBL] [Abstract][Full Text] [Related]
7. Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.
Picillo M; Pivonello R; Santangelo G; Pivonello C; Savastano R; Auriemma R; Amboni M; Scannapieco S; Pierro A; Colao A; Barone P; Pellecchia MT
PLoS One; 2017; 12(10):e0186508. PubMed ID: 29065116
[TBL] [Abstract][Full Text] [Related]
8. Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease.
Aziz NA; Pijl H; Frölich M; Roelfsema F; Roos RA
J Neuroendocrinol; 2011 Jun; 23(6):519-24. PubMed ID: 21466597
[TBL] [Abstract][Full Text] [Related]
9. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
[TBL] [Abstract][Full Text] [Related]
10. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor-1 and nitric oxide levels in Parkinson's disease.
Tuncel D; Inanc Tolun F; Toru I
Mediators Inflamm; 2009; 2009():132464. PubMed ID: 19300521
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
[TBL] [Abstract][Full Text] [Related]
14. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
[TBL] [Abstract][Full Text] [Related]
15. The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features.
Pellecchia MT; Pivonello R; Monsurrò MR; Trojsi F; Longo K; Piccirillo G; Pivonello C; Rocco M; Di Somma C; Colao A; Tedeschi G; Barone P
Eur J Neurol; 2010 May; 17(5):666-71. PubMed ID: 20002733
[TBL] [Abstract][Full Text] [Related]
16. Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson's Disease: A Meta-Analysis.
Li DH; He YC; Quinn TJ; Liu J
PLoS One; 2015; 10(12):e0144755. PubMed ID: 26657015
[TBL] [Abstract][Full Text] [Related]
17. Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure.
Ghazi Sherbaf F; Mohajer B; Ashraf-Ganjouei A; Mojtahed Zadeh M; Javinani A; Sanjari Moghaddam H; Shirin Shandiz M; Aarabi MH
Front Endocrinol (Lausanne); 2018; 9():608. PubMed ID: 30450079
[No Abstract] [Full Text] [Related]
18. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
[TBL] [Abstract][Full Text] [Related]
19. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
